Carcinogenesis Advance Access originally published online on May 22, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis, Vol. 24, No. 7, 1167-1176,
July 2003
© 2003 Oxford University Press
COMMENTARY |
Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms
Laboratory of Biosystems and Cancer, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 37, Room 5046, MSC-4264, Bethesda, MD 20892, USA
1 To whom correspondence should be addressed Email: horikawi{at}mail.nih.gov
Malignant transformation from mortal, normal cells to immortal, cancer cells is generally associated with activation of telomerase and subsequent telomere maintenance. A major mechanism to regulate telomerase activity in human cells is transcriptional control of the telomerase catalytic subunit gene, human telomerase reverse transcriptase (hTERT). Several transcription factors, including oncogene products (e.g. c-Myc) and tumor suppressor gene products (e.g. WT1 and p53), are able to control hTERT transcription when over-expressed, although it remains to be determined whether a cancer-associated alteration of these factors is primarily responsible for the hTERT activation during carcinogenic processes. Microcell-mediated chromosome transfer experiments have provided evidence for endogenous factors that function to repress the telomerase activity in normal cells and are inactivated in cancer cells. At least one of those endogenous telomerase repressors, which is encoded by a putative tumor suppressor gene on chromosome 3p, acts through transcriptional repression of the hTERT gene. The hTERT gene is also a target site for viruses frequently associated with human cancers, such as human papillomavirus (HPV) and hepatitis B virus (HBV). HPV E6 protein contributes to keratinocyte immortalization and carcinogenesis through trans-activation of the hTERT gene transcription. In at least some hepatocellular carcinomas, the hTERT gene is a non-random integration site of HBV genome, which activates in cis the hTERT transcription. Thus, a variety of cellular and viral oncogenic mechanisms converge on transcriptional control of the hTERT gene. Regulation of chromatin structure through the modification of nucleosomal histones may mediate the action of these cellular and viral mechanisms. Further elucidation of the hTERT transcriptional regulation, including identification and characterization of the endogenous repressor proteins, should lead to better understanding of the complex regulation of human telomerase in normal and cancer cells and may open up new strategies for anticancer therapy.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Cao, L. I. Huschtscha, A. S. Nouwens, H. A. Pickett, A. A. Neumann, A. C-M. Chang, C. D. Toouli, T. M. Bryan, and R. R. Reddel Amplification of Telomerase Reverse Transcriptase Gene in Human Mammary Epithelial Cells with Limiting Telomerase RNA Expression Levels Cancer Res., May 1, 2008; 68(9): 3115 - 3123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bellon and C. Nicot Regulation of Telomerase and Telomeres: Human Tumor Viruses Take Control J Natl Cancer Inst, January 16, 2008; 100(2): 98 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-W. Cheng, M.-F. Wu, J. Wang, K.-T. Yeh, Y.-G. Goan, H.-L. Chiou, C.-Y. Chen, and H. Lee Human Papillomavirus 16/18 E6 Oncoprotein Is Expressed in Lung Cancer and Related with p53 Inactivation Cancer Res., November 15, 2007; 67(22): 10686 - 10693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Benanti, M. L. Wang, H. E. Myers, K. L. Robinson, C. Grandori, and D. A. Galloway Epigenetic Down-Regulation of ARF Expression Is a Selection Step in Immortalization of Human Fibroblasts by c-Myc Mol. Cancer Res., November 1, 2007; 5(11): 1181 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Wooten-Blanks, P. Song, C. E. Senkal, and B. Ogretmen Mechanisms of ceramide-mediated repression of the human telomerase reverse transcriptase promoter via deacetylation of Sp3 by histone deacetylase 1 FASEB J, October 1, 2007; 21(12): 3386 - 3397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Oikonomou, I. Messinis, and A. Tsezou DNA Methylation Is Not Likely to Be Responsible for hTERT Expression in Premalignant Cervical Lesions Experimental Biology and Medicine, July 1, 2007; 232(7): 881 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Liu, X. Fang, Z. Ge, M. Jalink, S. Kyo, M. Bjorkholm, A. Gruber, J. Sjoberg, and D. Xu The Telomerase Reverse Transcriptase (hTERT) Gene Is a Direct Target of the Histone Methyltransferase SMYD3 Cancer Res., March 15, 2007; 67(6): 2626 - 2631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sato, M. B. Vaughan, L. Girard, M. Peyton, W. Lee, D. S. Shames, R. D. Ramirez, N. Sunaga, A. F. Gazdar, J. W. Shay, et al. Multiple Oncogenic Changes (K-RASV12, p53 Knockdown, Mutant EGFRs, p16 Bypass, Telomerase) Are Not Sufficient to Confer a Full Malignant Phenotype on Human Bronchial Epithelial Cells Cancer Res., February 15, 2006; 66(4): 2116 - 2128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-M. Chen, Z.-Z. Tao, Q.-Q. Hua, D. Liu, H.-M. Chi, and Q. Cai Inhibition of human telomerase reverse transcriptase in hep-2 cells using short hairpin RNA expression vectors. Arch Otolaryngol Head Neck Surg, February 1, 2006; 132(2): 200 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Ge, C. Liu, M. Bjorkholm, A. Gruber, and D. Xu Mitogen-Activated Protein Kinase Cascade-Mediated Histone H3 Phosphorylation Is Critical for Telomerase Reverse Transcriptase Expression/Telomerase Activation Induced by Proliferation Mol. Cell. Biol., January 1, 2006; 26(1): 230 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Horikawa, Y. J. Chiang, T. Patterson, L. Feigenbaum, S.-H. Leem, E. Michishita, V. Larionov, R. J. Hodes, and J. C. Barrett Differential cis-regulation of human versus mouse TERT gene expression in vivo: Identification of a human-specific repressive element PNAS, December 20, 2005; 102(51): 18437 - 18442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Renaud, D. Loukinov, F. T. Bosman, V. Lobanenkov, and J. Benhattar CTCF binds the proximal exonic region of hTERT and inhibits its transcription Nucleic Acids Res., December 2, 2005; 33(21): 6850 - 6860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Faiola, X. Liu, S. Lo, S. Pan, K. Zhang, E. Lymar, A. Farina, and E. Martinez Dual Regulation of c-Myc by p300 via Acetylation-Dependent Control of Myc Protein Turnover and Coactivation of Myc-Induced Transcription Mol. Cell. Biol., December 1, 2005; 25(23): 10220 - 10234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Quante, S. Heeg, A. von Werder, G. Goessel, C. Fulda, M. Doebele, H. Nakagawa, R. Beijersbergen, H. E. Blum, and O. G. Opitz Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis Carcinogenesis, November 1, 2005; 26(11): 1879 - 1889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Wooten and B. Ogretmen Sp1/Sp3-dependent Regulation of Human Telomerase Reverse Transcriptase Promoter Activity by the Bioactive Sphingolipid Ceramide J. Biol. Chem., August 12, 2005; 280(32): 28867 - 28876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Murakami, K Saigo, H Takashima, M Minami, T Okanoue, C Brechot, and P Paterlini-Brechot Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas Gut, August 1, 2005; 54(8): 1162 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Phillips, S. R. Hood, G. G. Gibson, and N. J. Plant IMPACT OF TRANSCRIPTION FACTOR PROFILE AND CHROMATIN CONFORMATION ON HUMAN HEPATOCYTE CYP3A GENE EXPRESSION Drug Metab. Dispos., February 1, 2005; 33(2): 233 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Sinha-Datta, I. Horikawa, E. Michishita, A. Datta, J. C. Sigler-Nicot, M. Brown, M. Kazanji, J. C. Barrett, and C. Nicot Transcriptional activation of hTERT through the NF-{kappa}B pathway in HTLV-I-transformed cells Blood, October 15, 2004; 104(8): 2523 - 2531. [Abstract] [Full Text] [PDF]
|
|